Follow-up time points | |||||
---|---|---|---|---|---|
Outcome measure | Description of prognostic variable | Prognostic variable | 2 weeks | 3 months | 12 months |
Diff. of. adj. R2 | Diff. of. adj. R2 | Diff. of. adj. R2 | |||
Pain intensity (Numeric Rating Scale, 0–10) | LCA-derived subgroupings | Single-stage subgroups | 0.028* | 0.014* | 0.026** |
Two-stage subgroups | 0.022* | 0.013* | 0.019* | ||
Existing subgrouping tools | STarT Back Tool | 0.014* | 0.001 | 0.003 | |
Quebec Task Force classification | 0.006 | 0.010* | 0.005 | ||
Baseline characteristics | Baseline leg pain intensity (0–10 Numeric Rating Scale) | 0.038** | 0.007* | 0.033** | |
Baseline disability (RMDQ-23) (0–100 = highest disability) | 0.006 | −0.001 | 0.000 | ||
Results of first stage of two-stage LCA | All domain-specific patient categorisations | 0.042** | 0.049** | 0.077** | |
Disability (23-item Roland Morris Disability Questionnaire, proportional score) | LCA-derived subgroupings | Single-stage subgroups | 0.047** | 0.041** | 0.024* |
Two-stage subgroups | 0.041** | 0.035* | 0.016 | ||
Existing subgrouping tools | STarT Back Tool | 0.020** | 0.020** | 0.003 | |
Quebec Task Force classification | 0.016** | 0.027* | 0.026* | ||
Baseline characteristics | Baseline back pain intensity (0–10 Numeric Rating Scale) | −0.009 | −0.003 | −0.007 | |
Baseline leg pain intensity (0–10 Numeric Rating Scale) | 0.032** | 0.028** | 0.042** | ||
Results of first stage of two-stage LCA | All domain-specific patient categorisations | 0.054** | 0.067** | 0.064** |